David Frazer, CEO of the National Pediatric Cancer Foundation (NPCF), discusses pediatric cancer and the fight to find less toxic, more targeted treatments. Ten drugs have been developed for use in children with cancer since 1980 as compared to hundreds created for adults. He talks about the progress and goal of the company.
David Frazer is the organization’s chief executive officer, leading the fight to find less toxic, more targeted treatments. He joined NPCF with over 25 years of experience, with a career spanning the private, public service and nonprofit sectors.
Dave joined the National Pediatric Cancer Foundation (NPCF) in August of 2015. As the Chief Executive Officer, Dave leads the general and active management of the business affairs of the Corporation and a 25 member board of directors. The NPCF is headquartered in Tampa, FL, and is a non-profit organization dedicated to funding research to eliminate childhood cancer. NPCF is focused on finding less toxic, more targeted therapies by partnering with leading hospitals nationwide.
Dave possesses a Masters Degree in Education. Originally from Pennsylvania, he is married with two children and lives in Land O’ Lakes, Florida.